These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27344167)

  • 1. Local and systemic renin-angiotensin system participates in cardiopulmonary-renal interactions in monocrotaline-induced pulmonary hypertension in the rat.
    Malikova E; Galkova K; Vavrinec P; Vavrincova-Yaghi D; Kmecova Z; Krenek P; Klimas J
    Mol Cell Biochem; 2016 Jul; 418(1-2):147-57. PubMed ID: 27344167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure.
    Pieruzzi F; Abassi ZA; Keiser HR
    Circulation; 1995 Nov; 92(10):3105-12. PubMed ID: 7586282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
    Bruce E; Shenoy V; Rathinasabapathy A; Espejo A; Horowitz A; Oswalt A; Francis J; Nair A; Unger T; Raizada MK; Steckelings UM; Sumners C; Katovich MJ
    Br J Pharmacol; 2015 May; 172(9):2219-31. PubMed ID: 25522140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of tanshinone II(A) on expression of different components in renin-angiotensin system of left ventricles of hypertensive rats].
    Yu LZ; Shi CR
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1468-72. PubMed ID: 25039184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid-X-receptor expression in monocrotaline-induced pulmonary arterial hypertension and right heart failure.
    Ye L; Jiang Y; Zuo X
    Biochem Biophys Res Commun; 2015 Nov; 467(1):164-70. PubMed ID: 26392308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac modulations of ANG II receptor expression in rats with hypoxic pulmonary hypertension.
    Adamy C; Oliviero P; Eddahibi S; Rappaport L; Samuel JL; Teiger E; Chassagne C
    Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H733-40. PubMed ID: 12124222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renal denervation on monocrotaline induced pulmonary remodeling.
    Liu Q; Song J; Lu D; Geng J; Jiang Z; Wang K; Zhang B; Shan Q
    Oncotarget; 2017 Jul; 8(29):46846-46855. PubMed ID: 28187460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats.
    Klimas J; Olvedy M; Ochodnicka-Mackovicova K; Kruzliak P; Cacanyiova S; Kristek F; Krenek P; Ochodnicky P
    J Cell Mol Med; 2015 Aug; 19(8):1965-74. PubMed ID: 25766467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression.
    Haga S; Tsuchiya H; Hirai T; Hamano T; Mimori A; Ishizaka Y
    Exp Lung Res; 2015 Feb; 41(1):21-31. PubMed ID: 25275723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.
    Jasmin JF; Cernacek P; Dupuis J
    Clin Sci (Lond); 2003 Dec; 105(6):647-53. PubMed ID: 12823096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of renin-angiotensin-aldosterone system (RAAS) in the lung of smoking-induced pulmonary arterial hypertension (PAH) rats.
    Yuan YM; Luo L; Guo Z; Yang M; Ye RS; Luo C
    J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):249-53. PubMed ID: 25795458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
    Kay JM; Keane PM; Suyama KL; Gauthier D
    Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling.
    Sugiyama A; Kaisho M; Okada M; Otani K; Yamawaki H
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oxidative stress, inflammation, nitric oxide and transforming growth factor-beta in the protective effect of diosgenin in monocrotaline-induced pulmonary hypertension in rats.
    Ahmed LA; Obaid AA; Zaki HF; Agha AM
    Eur J Pharmacol; 2014 Oct; 740():379-87. PubMed ID: 25062790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.
    Ferreira AJ; Shenoy V; Yamazato Y; Sriramula S; Francis J; Yuan L; Castellano RK; Ostrov DA; Oh SP; Katovich MJ; Raizada MK
    Am J Respir Crit Care Med; 2009 Jun; 179(11):1048-54. PubMed ID: 19246717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension.
    Correia-Pinto J; Henriques-Coelho T; Roncon-Albuquerque R; Lourenço AP; Melo-Rocha G; Vasques-Nóvoa F; Gillebert TC; Leite-Moreira AF
    Basic Res Cardiol; 2009 Sep; 104(5):535-45. PubMed ID: 19288153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Effects of Renal Denervation on Pulmonary Vascular Remodeling in Experimental Pulmonary Artery Hypertension.
    Qingyan Z; Xuejun J; Yanhong T; Zixuan D; Xiaozhan W; Xule W; Zongwen G; Wei H; Shengbo Y; Congxin H
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):562-70. PubMed ID: 25804321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.